Suppr超能文献

使用N-甲基吡咯烷酮提高药物溶解度

Solubility improvement of drugs using N-methyl pyrrolidone.

作者信息

Sanghvi Ritesh, Narazaki Ryuichi, Machatha Stephen G, Yalkowsky Samuel H

机构信息

College of Pharmacy, The University of Arizona, 1703 E. Mabel Street, Tucson, Arizona 85721-0207, USA.

出版信息

AAPS PharmSciTech. 2008;9(2):366-76. doi: 10.1208/s12249-008-9050-z. Epub 2008 Feb 20.

Abstract

The solubilization efficiency of N-methyl pyrrolidone (NMP) has been determined and compared to that of ethanol and propylene glycol for 13 poorly soluble drugs. NMP is found to be a more efficient solubilizer for all the drugs studied. The solubility enhancement as high as about 800-fold is obtained in 20% v/v NMP solution as compared to water. The mechanism of drug solubilization by NMP has also been investigated. It is proposed that NMP enhances drug solubility by simultaneously acting as a cosolvent and a complexing agent. A mathematical model is used to estimate the drug solubility in NMP-water mixture, according to which the total solubility enhancement is a sum of the two effects. This model describes the experimental data well and is more accurate than other models. A large and uniform reduction in the surface tension of water as a function of NMP concentration demonstrates its cosolvent effect. The complexation is supported by the fact that it's strength is affected by the temperature and the polarity of the medium. A strong correlation exists between log K (ow) of the drugs and the cosolvency coefficients. The correlation between log K (ow) and the complexation coefficients is weak suggesting that factors such as molecular shape and aromaticity of the drug molecule are significant in determining the complexation strength. This has been confirmed by the absence of a significant complexation between NMP and linear drug-like solutes.

摘要

已测定N-甲基吡咯烷酮(NMP)对13种难溶性药物的增溶效率,并与乙醇和丙二醇进行了比较。结果发现,对于所有研究的药物,NMP都是一种更有效的增溶剂。与水相比,在20%(v/v)的NMP溶液中,药物溶解度提高了约800倍。还研究了NMP增溶药物的机制。有人提出,NMP通过同时作为助溶剂和络合剂来提高药物溶解度。使用一个数学模型来估计药物在NMP-水混合物中的溶解度,根据该模型,总溶解度的提高是这两种作用的总和。该模型能很好地描述实验数据,并且比其他模型更准确。随着NMP浓度的变化,水的表面张力大幅且均匀地降低,这证明了其助溶作用。络合作用得到了如下事实的支持:其强度受温度和介质极性的影响。药物的log K(ow)与助溶系数之间存在很强的相关性。log K(ow)与络合系数之间的相关性较弱,这表明药物分子的分子形状和芳香性等因素在决定络合强度方面很重要。NMP与线性类药物溶质之间不存在显著络合,这证实了这一点。

相似文献

1
Solubility improvement of drugs using N-methyl pyrrolidone.
AAPS PharmSciTech. 2008;9(2):366-76. doi: 10.1208/s12249-008-9050-z. Epub 2008 Feb 20.
2
Solubilization of poorly soluble compounds using 2-pyrrolidone.
Int J Pharm. 2007 Sep 5;342(1-2):1-5. doi: 10.1016/j.ijpharm.2007.03.056. Epub 2007 May 10.
3
Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.
Int J Pharm. 2010 Jun 30;393(1-2):48-54. doi: 10.1016/j.ijpharm.2010.03.059. Epub 2010 Apr 2.
4
Review of pharmaceutical applications of N-methyl-2-pyrrolidone.
J Pharm Pharm Sci. 2010;13(4):524-35. doi: 10.18433/j3p306.
5
Bilinear model for the prediction of drug solubility in ethanol/water mixtures.
J Pharm Sci. 2005 Dec;94(12):2731-4. doi: 10.1002/jps.20492.
6
Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
Eur J Pharm Sci. 2006 May;28(1-2):7-14. doi: 10.1016/j.ejps.2005.11.012. Epub 2006 Jan 6.
7
Toxicity Study of a Self-nanoemulsifying Drug Delivery System Containing N-methyl pyrrolidone.
Drug Res (Stuttg). 2015 Aug;65(8):446-8. doi: 10.1055/s-0034-1389985. Epub 2015 Feb 17.
8
Solubility prediction of drugs in mixed solvents using partial solubility parameters.
J Pharm Sci. 2011 Oct;100(10):4368-82. doi: 10.1002/jps.22589. Epub 2011 May 31.
10
Solubilization by cosolvents. Establishing useful constants for the log-linear model.
Int J Pharm. 2002 Oct 1;245(1-2):153-66. doi: 10.1016/s0378-5173(02)00334-4.

引用本文的文献

1
Role of Solvents in Iron Nanoparticle Synthesis: Analyzing Water and 1‑Methyl-2-Pyrrolidone with Green Tea Extract as a Reducing Agent.
ACS Omega. 2025 Jul 10;10(28):30985-30995. doi: 10.1021/acsomega.5c03914. eCollection 2025 Jul 22.
2
Skin penetration enhancers: Mechanistic understanding and their selection for formulation and design.
Drug Deliv Transl Res. 2025 Feb 21. doi: 10.1007/s13346-025-01809-9.
9
-Methyl-2-pyrrolidone as a Reaction Medium for Gold(III)-Ion Reduction and Star-like Gold Nanostructure Formation.
ACS Omega. 2022 Mar 11;7(11):9484-9495. doi: 10.1021/acsomega.1c06835. eCollection 2022 Mar 22.
10
Tissue-reactive drugs enable materials-free local depots.
J Control Release. 2022 Mar;343:142-151. doi: 10.1016/j.jconrel.2022.01.023. Epub 2022 Jan 22.

本文引用的文献

1
Solubilization of poorly soluble compounds using 2-pyrrolidone.
Int J Pharm. 2007 Sep 5;342(1-2):1-5. doi: 10.1016/j.ijpharm.2007.03.056. Epub 2007 May 10.
2
Bilinear model for the prediction of drug solubility in ethanol/water mixtures.
J Pharm Sci. 2005 Dec;94(12):2731-4. doi: 10.1002/jps.20492.
3
Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
J Pharm Sci. 2005 Apr;94(4):912-7. doi: 10.1002/jps.20291.
4
SOLUBILITY OF SALICYLIC ACID AS A FUNCTION OF DIELECTRIC CONSTANT.
J Pharm Sci. 1964 Nov;53:1349-53. doi: 10.1002/jps.2600531114.
5
Solubilization by cosolvents. Establishing useful constants for the log-linear model.
Int J Pharm. 2002 Oct 1;245(1-2):153-66. doi: 10.1016/s0378-5173(02)00334-4.
7
Mechanistic studies on hydrotropic solubilization of nifedipine in nicotinamide solution.
Chem Pharm Bull (Tokyo). 1998 Jan;46(1):125-30. doi: 10.1248/cpb.46.125.
8
Solubility of organic solutes in ethanol/water mixtures.
J Pharm Sci. 1994 Dec;83(12):1735-40. doi: 10.1002/jps.2600831217.
10
Extended Hildebrand solubility approach: solubility of theophylline in polar binary solvents.
J Pharm Sci. 1980 May;69(5):487-91. doi: 10.1002/jps.2600690503.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验